PB

Pankajbhai Babubhai Savaj

Active Director Director DIN 09119526
DIN 09119526 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Pankajbhai Babubhai Savaj

Data last updated:

Pankajbhai Babubhai Savaj is a Director at Zlymo Pharmaceutical Private Limited (since 2021). The company operates in Pharma.

DIN 09119526
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zlymo Pharmaceutical Private Limited U24239GJ2021PTC121476
Director23 Mar 20212021Active

Board colleagues of Pankajbhai Babubhai Savaj

Directorship timeline

Open interactive timeline →
Zlymo Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Pankajbhai Babubhai Savaj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankajbhai Babubhai Savaj

Pankajbhai Babubhai Savaj currently holds 1 directorship: Zlymo Pharmaceutical Private Limited (Director, since 23 Mar 2021).

Pankajbhai Babubhai Savaj was first appointed on 23 Mar 2021 as Director at Zlymo Pharmaceutical Private Limited.

The current boards of Pankajbhai Babubhai Savaj's companies include Piyush Dungarbhai Sutariya (Zlymo Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available